"covid-19* convalescent plasma.

Ended Other Transaction Agreement Awarded Last action

Contract number
W911QY2090012
Awardee
Awarding agency
Obligated
$53,539,765

Award facts

Contract value 100% obligated
$53,539,765.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other
Place of performance
Baltimore, MD 21218, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00010 · No cost extension. $0
Other Administrative Action P00008 · "covid-19" no cost extension. $0
Other Administrative Action P00007 · "covid-19" no cost extension for 30 days $0
Supplemental Agreement for work within scope P00006 · "covid-19" additional costs and completion extension. $6,156,942
Supplemental Agreement for work within scope P00005 · "covid-19" definitization of costs under P00004. $0
Change Order P00004 · "covid-19" additional efforts to develop the prototype. $1,801,249
Supplemental Agreement for work within scope P00003 · "covid-19" additional development. $10,531,251
Supplemental Agreement for work within scope P00002 · "covid-19" revision to scope to include additional CRO efforts. $0
Supplemental Agreement for work within scope P00001 · "covid-19" additional clinical sites for testing. $18,429,698
Original award $16,620,625

About this award

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $53.5 million other transaction agreement to The Johns Hopkins University under a COVID-19 convalescent plasma program. The prime contractor, Johns Hopkins University, will utilize the funds to support research and development efforts relating to convalescent plasma as part of the Department of Defense's medical countermeasures portfolio. Performance will take place in Baltimore, Maryland through September 2022. No set aside designation or subcontractors were indicated. This award advances the Defense Department's goal of developing medical solutions to combat novel threats like the COVID-19 pandemic.

Quick answers

Who was awarded contract W911QY2090012?

W911QY2090012 was awarded to The Johns Hopkins University by ACC Aberdeen Proving Ground (Army Contracting Command) on June 8, 2020.

How much is contract W911QY2090012 worth?

The government has obligated $53,539,765 on W911QY2090012.

Which agency awarded contract W911QY2090012?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY2090012, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY2090012 competed?

The extent of competition for W911QY2090012 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award